Oncology Working Party

The European Medicines Agency's (EMA) Oncology Working Party (ONCWP) was set up by the Committee for Medicinal Products for Human Use (CHMP) in order to carry out specific tasks related to oncology (including haematological malignancies).

The working party's tasks include:

• preparing, reviewing and updating guidelines and concept papers on working party related matters;
• European and international co-operation relating to working party activities;
• liaising with interested parties, such as industry, patient organisations and healthcare professional organisations;
• providing trainings and workshops to assessors;
• providing product related support upon request from EMA Committees and the Scientific Advice Working Party.

Mandate, rules of procedure and work programme

Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains

Reference Number: EMA/299541/2025

Consolidated 3-year rolling work plan for the Oncology Working Party : January 2025 - December 2027

Summary:

Work plan period: January 2025 – December 2027 (with a first review point after one year)

Composition

The working party is composed of five to nine experts from Member States, selected from the list of European experts and nominated by members of the CHMP. Experts are chosen on the basis of the best and available expertise needed for the working party to deliver its commitments.

The current members are listed below, in alphabetical order of surname. Their declarations of interests are available in the European experts list: 

• European experts

Members

• Pierre Demolis (Chair)
• Ulrike Hermes
• Olga Kholmanskikh
• Joao Manuel Lopes de Oliveira
• Serena Marchetti
• Odoardo Maria Olimpieri
• Nuno Sousa
• Olli Tenhunen (Vice-chair)
• Michal Zwiewka